83089-23-0 Usage
Uses
Used in Pharmaceutical Synthesis:
Ethyl 4-(4-aminobutyl)piperazine-1-carboxylate is used as a key intermediate in the synthesis of various pharmaceuticals and organic compounds. Its versatile structure allows for the creation of a wide range of therapeutic agents.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, Ethyl 4-(4-aminobutyl)piperazine-1-carboxylate is used as a research compound for exploring its potential biological activity and its implications for drug development.
Used in Drug Discovery:
Ethyl 4-(4-aminobutyl)piperazine-1-carboxylate is utilized in drug discovery processes to identify new drug candidates and optimize their properties for specific therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 83089-23-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,0,8 and 9 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 83089-23:
(7*8)+(6*3)+(5*0)+(4*8)+(3*9)+(2*2)+(1*3)=140
140 % 10 = 0
So 83089-23-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H23N3O2/c1-2-16-11(15)14-9-7-13(8-10-14)6-4-3-5-12/h2-10,12H2,1H3
83089-23-0Relevant academic research and scientific papers
Process for the preparation of triazoloquinazolinones
-
, (2008/06/13)
A novel process for the preparation of triazoloquinazolinones of the formula STR1 wherein X is selected from the group consisting of hydrogen, fluorine, chlorine, bromine, --NO2, --CF3, --CH3 and --OCH3, n is an integer from 2 to 5, R1 and R2 are individually selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms and hydroxyalkyl of 1 to 5 carbon atoms or taken together with the nitrogen atom which they are attached form a saturated heterocycle optionally containing another heteroatom and optionally substituted with at least one member of the group consisting of hydroxy, alkyl and hydroxy alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, acyl of an aliphatic carboxylic acid of 1 to 5 carbon atoms, alkoxycarbonyl of 2 to 6 carbon atoms, aryl and aryl substituted with halogen or --CF3 and their non-toxic, pharmaceutically acceptable acid addition salts having antihistaminic and bronchospasmolytic activity and novel intermediates.
